Multiple Assemblies exist for SMTL entry 4ogv
Co-Crystal Structure of MDM2 with Inhibitor Compound 49; X-RAY DIFFRACTION 2.20 Å

	SMTL ID 4ogv.1 Ligands [(2S,5R,6R)-4-[(2S)-1-(tert-butylsulfonyl)butan-2-yl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl]acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer
	SMTL ID 4ogv.2 Ligands [(2S,5R,6R)-4-[(2S)-1-(tert-butylsulfonyl)butan-2-yl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl]acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer
	SMTL ID 4ogv.3 Ligands [(2S,5R,6R)-4-[(2S)-1-(tert-butylsulfonyl)butan-2-yl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl]acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer